Skip to main content
. 2024 Feb 23;10(8):eadj9945. doi: 10.1126/sciadv.adj9945

Fig. 2. NAb responses to SARS-CoV-2 Omicron and XBB subvariants.

Fig. 2.

NAb titers against the WA1/2020, BA.2, BA.5, BQ.1.1, XBB.1, XBB.1.5, and XBB.1.16 variants by luciferase-based pseudovirus neutralization assays at baseline before boosting, at week 3 following boosting, and at month 3 following boosting in nucleocapsid seronegative participants are shown. Median NAb titers (red bars) are depicted and shown numerically. LOD indicated by dotted lines represents the starting dilution used for the NAb assay, 1:20.